Average Co-Inventor Count = 5.71
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (11 from 2,078 patents)
2. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,539 patents)
3. Washington University (1 from 1,585 patents)
4. Convergene, LLC (6 patents)
12 patents:
1. 11426415 - Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders
2. 11098016 - Indazole derivatives useful as glucagon receptor antagonists
3. 10774048 - Indazole derivatives useful as glucagon receptor antagonists
4. 10662170 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
5. 10214493 - Indazole derivatives useful as glucagon receptor antagonists
6. 10131648 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
7. 10000473 - Indazole derivatives useful as glucagon receptor antagonists
8. 9790198 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
9. 9238658 - Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors
10. 9102669 - Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors
11. 8748624 - Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists
12. 7803793 - Heterocyclic derived metalloprotease inhibitors